ActiQs / Forskning

PUBLIKATIONSREGISTRET

Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för amifostine. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

38 träffar

Bibliografisk träff 2013-08-01

Dose escalation of amifostine for radioprotection during pelvic accelerated radiotherapy.

Koukourakis MI, Kyrgias G, Panteliadou M, Papadopoulou A, Tsiarkatsi M, Papachristou E, Bebeli M.

Am J Clin Oncol · clinical trial, phase ii; multicenter study; journal article · DOI 10.1097/coc.0b013e318248d882

Bibliografisk träff 2013-01-01

Efficacy of amifostine in protection against doxorubicin-induced acute cardiotoxic effects in rats.

Dragojević-Simić V, Dobrić S, Jaćević V, Bokonjić D, Milosavljević I, Kovacević A, Mikić D.

Vojnosanit Pregl · journal article · DOI 10.2298/vsp110905041d

Bibliografisk träff 2012-12-01

Quantitative histologic evidence of amifostine-induced cytoprotection in an irradiated murine model of mandibular distraction osteogenesis.

Tchanque-Fossuo CN, Donneys A, Razdolsky ER, Monson LA, Farberg AS, Deshpande SS, Sarhaddi D, Poushanchi B, Goldstein SA, Buchman SR.

Plast Reconstr Surg · research-article; evaluation study; journal article; research support, n.i.h., extramural · DOI 10.1097/prs.0b013e31826d2201

Bibliografisk träff 2012-10-03

Postmastectomy hypofractionated and accelerated radiation therapy with (and without) subcutaneous amifostine cytoprotection.

Koukourakis MI, Panteliadou M, Abatzoglou IM, Sismanidou K, Sivridis E, Giatromanolaki A.

Int J Radiat Oncol Biol Phys · journal article · DOI 10.1016/j.ijrobp.2012.08.017

Bibliografisk träff 2012-10-03

Systematic review of amifostine for the management of oral mucositis in cancer patients.

Nicolatou-Galitis O, Sarri T, Bowen J, Di Palma M, Kouloulias VE, Niscola P, Riesenbeck D, Stokman M, Tissing W, Yeoh E, Elad S, Lalla RV, Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO).

Support Care Cancer · research support, non-u.s. gov't; systematic review; consensus statement; journal article · DOI 10.1007/s00520-012-1613-6

Bibliografisk träff 2012-10-01

Meta-analysis of the efficacy of amifostine in the prevention of cisplatin ototoxicity.

Duval M, Daniel SJ.

J Otolaryngol Head Neck Surg · meta-analysis; systematic review; journal article

Bibliografisk träff 2012-09-01

[Effect of amifostine on locally advanced non-small cell lung cancer patients treated with radiotherapy: a meta-analysis of randomized controlled trials].

Wang S, Zhang Y, Zhang S, Ma S.

Zhongguo Fei Ai Za Zhi · meta-analysis; research-article; journal article; english abstract · DOI 10.3779/j.issn.1009-3419.2012.09.06

Bibliografisk träff 2012-08-03

Raman spectroscopy demonstrates Amifostine induced preservation of bone mineralization patterns in the irradiated murine mandible.

Tchanque-Fossuo CN, Gong B, Poushanchi B, Donneys A, Sarhaddi D, Gallagher KK, Deshpande SS, Goldstein SA, Morris MD, Buchman SR.

Bone · research-article; journal article; research support, n.i.h., extramural · DOI 10.1016/j.bone.2012.07.029

Bibliografisk träff 2012-07-15

The effect of amifostine on submandibular gland histology after radiation.

Junn JC, Sciubba JJ, Bishop JA, Zinreich E, Tang M, Levine MA, Palermo RA, Fakhry C, Blanco RG, Saunders JR, Califano JA, Ha PK.

Int J Otolaryngol · research-article; journal article · DOI 10.1155/2012/508279

Bibliografisk träff 2012-04-10

Reduction of renal uptake of radiolabeled octreotate by amifostine coadministration.

Melis M, Valkema R, Krenning EP, de Jong M.

J Nucl Med · research support, non-u.s. gov't; journal article · DOI 10.2967/jnumed.111.098665

Bibliografisk träff 2012-04-01

Amifostine remediates the degenerative effects of radiation on the mineralization capacity of the murine mandible.

Tchanque-Fossuo CN, Donneys A, Deshpande SS, Nelson NS, Boguslawski MJ, Gallagher KK, Sarhaddi D, Poushanchi B, Goldstein SA, Buchman SR.

Plast Reconstr Surg · research-article; journal article; research support, n.i.h., extramural · DOI 10.1097/prs.0b013e3182454352

Bibliografisk träff 2012-03-21

A phase I clinical and pharmacology study using amifostine as a radioprotector in dose-escalated whole liver radiation therapy.

Feng M, Smith DE, Normolle DP, Knol JA, Pan CC, Ben-Josef E, Lu Z, Feng MR, Chen J, Ensminger W, Lawrence TS.

Int J Radiat Oncol Biol Phys · research support, non-u.s. gov't; research-article; clinical trial, phase i; journal article; research support, n.i.h., extramural · DOI 10.1016/j.ijrobp.2011.10.020

Bibliografisk träff 2012-03-03

Amifostine, a radioprotectant agent, protects rat brain tissue lipids against ionizing radiation induced damage: an FTIR microspectroscopic imaging study.

Cakmak G, Miller LM, Zorlu F, Severcan F.

Arch Biochem Biophys · research support, non-u.s. gov't; research support, u.s. gov't, non-p.h.s.; journal article · DOI 10.1016/j.abb.2012.02.012

Bibliografisk träff 2012-01-19

Effects of amifostine in combination with cyclophosphamide on female reproductive system.

Barekati Z, Golkar-Narenji A, Totonchi M, Radpour R, Gourabi H.

Reprod Sci · research support, non-u.s. gov't; journal article · DOI 10.1177/1933719111426599

Bibliografisk träff 2011-08-01

Severe allergic reactions to thiol-based cytoprotective agents mesna and amifostine in a child with a supratentorial primitive neuroectodermal tumor.

Dorris K, Fouladi M, Davies SM, Perentesis JP, Lawrence JM, Chow LM, Assa'ad A, Uygungil B, Jodele S.

J Pediatr Hematol Oncol · research support, non-u.s. gov't; journal article; case reports · DOI 10.1097/mph.0b013e31820c3403

Bibliografisk träff 2011-02-24

Radiation-induced chronic oxidative renal damage can be reduced by amifostine.

Cosar R, Yurut-Caloglu V, Eskiocak S, Ozen A, Altaner S, Ibis K, Turan N, Denizli B, Uzal C, Saynak M, Parlar S, Caloglu M, Uregen B, Kocak Z.

Med Oncol · journal article · DOI 10.1007/s12032-011-9870-7

Bibliografisk träff 2010-03-24

The cytoprotective drug amifostine modifies both expression and activity of the pro-angiogenic factor VEGF-A.

Dedieu S, Canron X, Rezvani HR, Bouchecareilh M, Mazurier F, Sinisi R, Zanda M, Moenner M, Bikfalvi A, North S.

BMC Med · research support, non-u.s. gov't; research-article; journal article · DOI 10.1186/1741-7015-8-19

Bibliografisk träff 2009-08-25

Antimutagenicity of amifostine against the anticancer drug fotemustine in the Drosophila somatic mutation and recombination (SMART) test.

Aydemir N, Sevim N, Celikler S, Vatan O, Bilaloglu R.

Mutat Res · research support, non-u.s. gov't; journal article · DOI 10.1016/j.mrgentox.2009.08.005

Bibliografisk träff 2008-07-01

Alternate delivery route for amifostine as a radio-/chemo-protecting agent.

Praetorius NP, Mandal TK.

J Pharm Pharmacol · research support, non-u.s. gov't; review; research support, u.s. gov't, non-p.h.s.; journal article; research support, n.i.h., extramural · DOI 10.1211/jpp.60.7.0001

Bibliografisk träff 2007-06-01

Amifostine: the first selective-target and broad-spectrum radioprotector.

Kouvaris JR, Kouloulias VE, Vlahos LJ.

Oncologist · research support, non-u.s. gov't; review; journal article · DOI 10.1634/theoncologist.12-6-738

Bibliografisk träff 2007-03-01

The effect of amifostine, a cytoprotective agent, on paraquat toxicity in mice.

Wills BK, Aks S, Maloney GE, Rhee J, Brand R, Sekosan M.

J Med Toxicol · research support, non-u.s. gov't; research-article; journal article · DOI 10.1007/bf03161031

Bibliografisk träff 2005-12-01

Commentary: the pharmacological antioxidant amifostine -- implications of recent research for integrative cancer care.

Block KI, Gyllenhaal C.

Integr Cancer Ther · review; journal article · DOI 10.1177/1534735405282842

Bibliografisk träff 2005-05-01

Amifostine has an inhibitory effect on the radiation-induced p53-branched cascade in the immature mouse ovary.

Yoon YD, Kim JH, Lee KH, Kim JK.

In Vivo · research support, non-u.s. gov't; journal article

Bibliografisk träff 2005-01-28

Time dependent protection of amifostine from renal and hematopoietic cisplatin induced toxicity.

Asna N, Lewy H, Ashkenazi IE, Deutsch V, Peretz H, Inbar M, Ron IG.

Life Sci · research support, non-u.s. gov't; journal article · DOI 10.1016/j.lfs.2004.09.028

Bibliografisk träff 2004-10-01

Interaction of amifostine and ionizing radiation on transcriptional patterns of apoptotic genes expressed in human microvascular endothelial cells (HMEC).

Khodarev NN, Kataoka Y, Murley JS, Weichselbaum RR, Grdina DJ.

Int J Radiat Oncol Biol Phys · research support, u.s. gov't, p.h.s.; journal article · DOI 10.1016/j.ijrobp.2004.04.060

Bibliografisk träff 2003-01-01

The radioprotective agent, amifostine, suppresses the reactivity of intralysosomal iron.

Yu Z, Eaton JW, Persson HL.

Redox Rep · research support, u.s. gov't, p.h.s.; research support, non-u.s. gov't; journal article · DOI 10.1179/135100003225003384

Bibliografisk träff 2002-12-01

Regional pharmacokinetics of amifostine in anesthetized dogs: role of the liver, gastrointestinal tract, lungs, and kidneys.

Levi M, Knol JA, Ensminger WD, DeRemer SJ, Dou C, Lunte SM, Bonner HS, Shaw LM, Smith DE.

Drug Metab Dispos · research support, u.s. gov't, p.h.s.; journal article · DOI 10.1124/dmd.30.12.1425

Bibliografisk träff 2002-12-01

[Radioprotective effects on head and neck tumors of amifostine--a broad-spectrum cytoprotection].

Huang R, Yu H, Kuang A.

Sheng Wu Yi Xue Gong Cheng Xue Za Zhi · review; journal article; english abstract

Bibliografisk träff 2002-11-01

Amifostine-induced toxic epidermal necrolysis during radiotherapy: a case report.

Demiral AN, Yerebakan O, Simşir V, Alpsoy E.

Jpn J Clin Oncol · journal article; case reports · DOI 10.1093/jjco/hyf095

Bibliografisk träff 2002-06-01

Radioprotection of lungs by amifostine is associated with reduction in profibrogenic cytokine activity.

Vujaskovic Z, Feng QF, Rabbani ZN, Anscher MS, Samulski TV, Brizel DM.

Radiat Res · research support, non-u.s. gov't; journal article · DOI 10.1667/0033-7587(2002)157[0656:rolbai]2.0.co;2